Expertise in
20
conditions

Gianfranco F. Ferraccioli

Rome, IT 
Expertise in
20
conditions
Rome, IT 
OverviewLocationsClinical Research

Overview

Gianfranco Ferraccioli practices in Rome, Italy. Mr. Ferraccioli is highly rated in 20 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Scleroderma, Systemic Sclerosis (SSc), and Tissue Biopsy.

His clinical research consists of co-authoring 203 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Rome, 00168, Italy
Other Locations
Bari, Italy
Italy
Milan, Italy
Trieste, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Tolerability, Safety and Activity of IDN5243, 4 mg Bid Intramuscularly in the Treatment of Low Back Pain. A Prospective, Open Label, Single-center, Uncontrolled Study
Tolerability, Safety and Activity of IDN5243, 4 mg Bid Intramuscularly in the Treatment of Low Back Pain. A Prospective, Open Label, Single-center, Uncontrolled Study
Enrollment Status: Withdrawn
Publish Date: July 22, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Dose-finding, Pharmacokinetic Phase I Study of the Human Monoclonal Antibody-cytokine Fusion Protein F8IL10 (Dekavil) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
A Dose-finding, Pharmacokinetic Phase I Study of the Human Monoclonal Antibody-cytokine Fusion Protein F8IL10 (Dekavil) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: May 18, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

203 Total Publications

Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients.
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients.
Journal: Journal of clinical medicine
Published: March 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ferraccioli's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 35 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile